Author:
Fadhil Sarab Nasr,Fadhel Suha Nasser
Reference25 articles.
1. L. Bruni, M. Diaz, M. Castellsagué,. E. Ferrer, F. X .Bosch,. and S. de Sanjosé, (Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Journal of Infectious Diseases, 2010), 202(12), pp. 1789–1799.
2. J.Ferlay, I.Soerjomataram, R.Dikshit, S.Eser, C. Mathers, M. Rebelo , D. Maxwell Parkin, D. Forman and F. Bray (Cancer incidence and mortality worldwide: sources, methods, and major patterns in GLOBOCAN 2012. International journal of cancer, 2015) pp. 136(5).
3. J. M Ferrante , D. C Fyffe, M.L Vega, A. K Piasecki, P. A Ohman-Strickland, B. F Crabtree (Family physicians' barriers to cancer screening in extremely obese patients. Obesity, 2010). 18(6), pp. 1153–1159
4. W. Health Organization (World Health Organization guidance note comprehensive cervical cancer prevention and control: a healthier future for girls and women, 2013).
5. B. R Obeidat, Z. O. Amarin, L. Alzaghal (Awareness, practice, and attitude to cervical Papanicolaou smear among female health care workers in Jordan. Eur J Cancer Care, 2012). pp. 21, 372–6.